CyberKnife^® stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study.

ABSTRACT:

Background

Few studies have investigated whether there is a difference in local control or overall survival rates following treatment with robotic stereotactic body radiation therapy (SBRT) with or without prior fiducial marker implantation. Our study aimed to investigate this in patients with primary or secondary lung tumors.

Methods

A retrospective study was conducted at the Institut de Cancérologie de Lorraine of patients treated for primary lung cancer or pulmonary oligometastases with SBRT from January 2013 to July 2016. We included patients at least 18 years old who had stage I non-small cell lung cancer (NSCLC) or lung metastases and a follow-up of at least 1 month.

Results

A total of 294 patients were included. Tumors included 122 lung metastases, 89 stage I N

SUBMITTER: Oudin V 

PROVIDER: S-EPMC10586995 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature